Accuray (ARAY) Cash from Operations Growth (5y) (2015 - 2026)
Accuray (ARAY) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Accuray | 28,055.41 | -38.51 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.80% |
| Dec 31, 2025 | -23.12% |
| Sep 30, 2025 | 44.24% |
| Mar 31, 2025 | 24.88% |
| Dec 31, 2024 | -35.75% |
| Sep 30, 2024 | 21.60% |
| Mar 31, 2024 | -25.03% |
| Dec 31, 2023 | 18.04% |
| Sep 30, 2023 | 13.58% |
| Mar 31, 2023 | 9.73% |
| Dec 31, 2022 | -90.77% |
| Sep 30, 2022 | 14.91% |
| Mar 31, 2022 | 16.86% |
| Dec 31, 2021 | 57.39% |
| Sep 30, 2021 | -4.92% |
| Mar 31, 2021 | 40.72% |
| Dec 31, 2020 | 19.17% |
| Sep 30, 2020 | -17.44% |
| Jun 30, 2020 | 65.51% |
| Mar 31, 2020 | -102.12% |